Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
2023 · Nature Communications · 33 citations
https://doi.org/10.1038/s41467-023-40758-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
803
Citations
9
h-index
7
i10-index
Claudia Tandler is an academic researcher from Research Institute for Work, Technology and Culture. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Acute Myeloid Leukemia Research. The author has an h-index of 9, co-authored 17 publications.
https://doi.org/10.1038/s41467-023-40758-0
https://doi.org/10.1038/s41598-019-54767-x
https://doi.org/10.1007/s00277-022-04756-4
Click to start Chat